Principal Financial Group Inc. Has $266,000 Holdings in ZimVie Inc. (NASDAQ:ZIMV)

Principal Financial Group Inc. grew its position in shares of ZimVie Inc. (NASDAQ:ZIMV) by 9.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,054 shares of the company’s stock after purchasing an additional 1,702 shares during the quarter. Principal Financial Group Inc. owned approximately 0.07% of ZimVie worth $266,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in ZIMV. Segall Bryant & Hamill LLC acquired a new stake in shares of ZimVie during the third quarter valued at about $891,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of ZimVie during the third quarter valued at about $470,000. Jacobs Levy Equity Management Inc. boosted its stake in shares of ZimVie by 1.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 398,306 shares of the company’s stock valued at $6,321,000 after purchasing an additional 6,235 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in shares of ZimVie during the third quarter valued at about $528,000. Finally, Barclays PLC boosted its stake in shares of ZimVie by 338.4% during the third quarter. Barclays PLC now owns 43,437 shares of the company’s stock valued at $690,000 after purchasing an additional 33,529 shares in the last quarter. 95.63% of the stock is owned by institutional investors and hedge funds.

ZimVie Price Performance

Shares of ZIMV opened at $12.55 on Friday. ZimVie Inc. has a 1 year low of $12.25 and a 1 year high of $22.40. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The company has a market capitalization of $347.35 million, a price-to-earnings ratio of -0.96 and a beta of 2.10. The business has a 50-day moving average of $13.70 and a 200-day moving average of $14.64.

ZimVie (NASDAQ:ZIMV) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The company had revenue of $111.52 million during the quarter, compared to the consensus estimate of $113.67 million. As a group, equities research analysts anticipate that ZimVie Inc. will post 0.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reissued a “buy” rating and set a $23.00 price target on shares of ZimVie in a research note on Thursday, February 27th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.